All Posts

We are excited to share that PMAC will be present at the San Antonio Breast Cancer Symposium (SABCS) 2025  with several impactful presentations. Connect with us at SABCS 2025 and share insights on advancing breast cancer research. Poster Spotlight 5 📍 December 11, 2025 | 7:00 AM–8:30 AM | Hemisfair 3 PD5-05 : Impact of circulating tumor DNA (ctDNA) surveillance on quality of life (QoL) for patients with early-stage breast cancer (EBC): prospective I-SURV study Presenter:  C

Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis Read the full article here: https://www.nature.com/articles/s41523-025-00802-2

Join us at ASCO 2025 and connect with our team during the poster sessions. We look forward to engaging discussions and sharing insights on advancing breast cancer care.

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer. Read the full article here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830759